Literature DB >> 23815591

Transmembrane domain V plays a stabilizing role in the function of human bile acid transporter SLC10A2.

Robyn H Moore1, Paresh Chothe, Peter W Swaan.   

Abstract

The human apical sodium-dependent bile acid transporter (hASBT, SLC10A2), primarily expressed in the ileum, is involved in both the recycling of bile acids and cholesterol homeostasis. In this study, the structure-function relationship of transmembrane domain 5 (TM5) residues involved in transport is elucidated. Cysteine scanning mutagenesis of each consecutive residue on TM5 resulted in 96% of mutants having a significantly decreased transport activity, although each was expressed at the cell surface. Specifically, G197 and I208 were no longer functional, and G201 and G212 functioned at a level of <10% upon cysteine mutation. Interestingly, each of these exists along one face of the helix. Studies suggest that neither G201 nor G212 is on the substrate pathway. Conservative alanine mutations of the four residues displayed a higher activity in all but G197A, indicating its functional importance. G197 and G201 form a GxxxG motif, which has been found to be important in helix-helix interactions. According to our model, G197 and G201 face transmembrane domain 4 (TM4) residues G179 and P175, respectively. Similarly, G212 faces G237, which forms part of a GxxxG domain in transmembrane domain 6 (TM6). It is possible that these GxxxG domains and their interacting partners are responsible for maintaining the structure of the helices and their interactions with one another. I205 and I208 are both in positions to anchor the GxxxG domains and direct the change in interaction of TM5 from TM4 to TM6. Combined, the results suggest that residues along TM5 are critical for ASBT function but are not directly involved in substrate translocation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815591      PMCID: PMC3812428          DOI: 10.1021/bi400028q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2.

Authors:  Tatiana Claro da Silva; Naissan Hussainzada; Chandra M Khantwal; James E Polli; Peter W Swaan
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

2.  Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.

Authors:  Anand Balakrishnan; Stephen A Wring; James E Polli
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

Review 3.  Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.

Authors:  Anand Balakrishnan; James E Polli
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

Review 4.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

Review 5.  Pore structure of the Cys-loop ligand-gated ion channels.

Authors:  Nathan L Absalom; Peter R Schofield; Trevor M Lewis
Journal:  Neurochem Res       Date:  2009-04-19       Impact factor: 3.996

6.  Electrostatic and potential cation-pi forces may guide the interaction of extracellular loop III with Na+ and bile acids for human apical Na+-dependent bile acid transporter.

Authors:  Antara Banerjee; Naissan Hussainzada; Akash Khandelwal; Peter W Swaan
Journal:  Biochem J       Date:  2008-03-01       Impact factor: 3.857

7.  The cytosolic half of helix III forms the substrate exit route during permeation events of the sodium/bile acid cotransporter ASBT.

Authors:  Naissan Hussainzada; Tatiana Claro Da Silva; Peter W Swaan
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

8.  Conserved aspartic acid residues lining the extracellular loop 1 of sodium-coupled bile acid transporter ASBT Interact with Na+ and 7alpha-OH moieties on the ligand cholestane skeleton.

Authors:  Naissan Hussainzada; Tatiana Claro Da Silva; Eric Y Zhang; Peter W Swaan
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

9.  Conformational flexibility of helix VI is essential for substrate permeation of the human apical sodium-dependent bile acid transporter.

Authors:  Naissan Hussainzada; Akash Khandewal; Peter W Swaan
Journal:  Mol Pharmacol       Date:  2007-10-30       Impact factor: 4.436

10.  Cytosolic half of transmembrane domain IV of the human bile acid transporter hASBT (SLC10A2) forms part of the substrate translocation pathway.

Authors:  Chandra M Khantwal; Peter W Swaan
Journal:  Biochemistry       Date:  2008-03-01       Impact factor: 3.162

View more
  5 in total

Review 1.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

2.  S-acylation modulates the function of the apical sodium-dependent bile acid transporter in human cells.

Authors:  Alexander L Ticho; Pooja Malhotra; Christopher R Manzella; Pradeep K Dudeja; Seema Saksena; Ravinder K Gill; Waddah A Alrefai
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

3.  Transmembrane domain II of the human bile acid transporter SLC10A2 coordinates sodium translocation.

Authors:  Hairat Sabit; Sairam S Mallajosyula; Alexander D MacKerell; Peter W Swaan
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

4.  Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system.

Authors:  Diana Vivian; James E Polli
Journal:  Eur J Pharm Sci       Date:  2014-08-27       Impact factor: 4.384

5.  Human bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers.

Authors:  Paresh P Chothe; Lindsay C Czuba; Robyn H Moore; Peter W Swaan
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-12-01       Impact factor: 3.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.